Company Filing History:
Years Active: 2009
Title: Gonzalo Canal Mori: Innovator in Pharmaceutical Chemistry
Introduction
Gonzalo Canal Mori is a notable inventor based in Leioa, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on creating effective treatments for allergic reactions and other conditions mediated by histamine.
Latest Patents
Gonzalo Canal Mori holds a patent for a polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid. This crystalline form, known as crystalline form 1, is described in detail in his patent. The patent outlines procedures for its preparation, pharmaceutical formulations containing this crystalline form, and its application in treating allergic reactions and pathological processes in mammals, including humans.
Career Highlights
Gonzalo is associated with Faes Farma, S.A., a prominent pharmaceutical company. His work at Faes Farma has allowed him to contribute to the development of innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry.
Collaborations
Gonzalo has collaborated with notable colleagues, including Aurelio Orjales Venero and Maravillas Bordell Martin. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Gonzalo Canal Mori's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patent for a novel crystalline form demonstrates his commitment to advancing treatment options for patients. His work continues to influence the field and improve healthcare outcomes.